Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 2026 commercial launch FINANCING needed now

<< Previous

Bullboard Posts

Next >>

Post by james700on Jun 28, 2023 8:28pm

396 Views

Post# 35519614

2026 commercial launch FINANCING needed now

So, according to financial statements and cash burn, Theralase needs to do some sort of financing to get the ball across the goal line. That financing should be any day now, because they will deplete their cash reserves within a month or so... Tick Tock let's see what's behind door number 2?

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs